Nebraska Medicine announces leadership changes, next CEO

After more than 40 years in a variety of roles for Nebraska Medicine, UNMC, and the University of Nebraska, James Linder, MD, will step down as Nebraska Medicine CEO on Tuesday, July 1. Dr. Linder has held the CEO title since August 2018. The Nebraska Medicine Board of Directors unanimously chose Michael Ash, MD, to succeed him as the next chief executive officer of the private, nonprofit health system. 

“Age 70 feels like a graceful time to step aside—creating space for a leader with a longer runway, while hopefully leaving me time to pursue interests outside of work,” says Dr. Linder. “There is tremendous uncertainty facing health care, but I have confidence that our organization is prepared to thrive in the next decade. As a nonprofit academic medical center, we have the people, knowledge, and culture to excel in our clinical, educational, and research missions.”

Dr. Linder says he and the board have been working on succession planning for the last several years and the clinical, business and leadership skills Dr. Ash brings to the role are the right fit at the right time.

“I’m delighted that Dr. Ash has accepted the role of CEO,” says Dr. Linder. “He understands Nebraska Medicine, possesses exceptional health care knowledge, and brings the right motivation to the role. Michael will empower our colleagues to do what’s best for patients.” 

Dr. Ash says he’s been grateful for Dr. Linder’s leadership, guidance and friendship throughout the years.

“We extend our sincere appreciation to Jim for his outstanding leadership, strategic vision, and enduring commitment to Nebraska Medicine,” says Dr. Ash. “Throughout his tenure, Jim has been more than a chief executive. He has been a mentor, a guiding force, and an inspiration through periods of growth and transformation. His innovative approach, unwavering dedication, and philanthropic spirit have left a lasting impact not only on our organization, but on the broader community we serve. Jim's legacy is one of integrity, service, and excellence and will continue to shape Nebraska Medicine for years to come.”

Prior to his 11 years with Nebraska Medicine and UNMC, Dr. Ash served as chief medical officer for the Cerner Corporation (now Oracle Health) and practiced as an internal medicine physician. He also holds a dozen health care technology patents.

As part of this leadership transition, Kyle Skiermont, PharmD, who currently serves as executive vice president of Operations, will be promoted to chief operating officer on July 1. 

“I am grateful and honored to have this opportunity,” says Dr. Skiermont. “Nebraska Medicine and UNMC are such special places for me. The thousands of extraordinary people who transform lives each day never stop inspiring me. I am truly fortunate to be part of this team.”